We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.60 | -1.78% | 33.10 | 32.95 | 33.85 | 33.95 | 32.95 | 33.95 | 1,864,058 | 16:35:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 195.88 | 179.87M |
TIDMAPH
RNS Number : 6019Q
Alliance Pharma PLC
30 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES ---------------------------------------------------------------------------------------------------------------- 1. Identity of the issuer or Alliance Pharma plc the underlying issuer of existing shares to which voting rights are attached: --------------------------------------------------------------- ----------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ---------------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights -------------------------------------------------------------------------------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------------------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------------------------------------------------- An event changing the breakdown of voting rights -------------------------------------------------------------------------------------------------------------- Other (please CHANGE IN NATURE : RETURN OF LOANED SHARES specify): ----------------------------------------------------------- ------------------------------------------------- 3. Full name of person(s) Aviva plc & its subsidiaries subject to the notification obligation: ------------------------------------------------------------- ------------------------------------------------- 4. Full name of shareholder(s) Registered Holder: (if different from 3.): Available on request 18,450* BNY Norwich Union Nominees Limited 2,744,814* Chase (GA Group) Nominees Limited 39,988,304* *denotes direct interest Chase Nominees Limited 1,382,120 ------------------------------------------------------------- ------------------------------------------------- 5. Date of the transaction 29 November 2016 and date on which the threshold is crossed or reached: ------------------------------------------------------------- ------------------------------------------------- 6. Date on which issuer 30 November 2016 notified: ------------------------------------------------------------- ------------------------------------------------- 7. Threshold(s) that is/are 8% to 9% Change at Direct crossed or Interest Level (Box 8A) reached: ------------------------------------------------------------- ------------------------------------------------- 8. Notified details: -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares -------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ---------------- ------------------------------ ------------------------------------------------------------ Number Number Number Number of voting % of voting of of of shares rights rights Shares Voting Rights ---------------- ---------------- ------------ ------------- ------------------------ ------------------- Direct Direct Indirect Direct Indirect ---------------- ---------------- ------------ ------------- ----------- ----------- ------- ---------- Ordinary Shares GB0031030819 44,241,981* 44,241,981* 44,133,688 42,751,568 1,382,120 9.06% 0.29% ---------------- ------------ ------------- ----------- ----------- ------- ---------- * Includes Right to Recall Loaned Shares (1,132,875) -------------------------------------------------------------------------------------------------------------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument Period may be acquired if the instrument is exercised/ converted. ---------------- ---------------- --------------------------- ------------------------ ------------------- 108,293* RIGHT TO RECALL LOANED SHARES N/A N/A *Direct Interest 0.02% ---------------- ---------------- --------------------------- ------------------------ ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights period refers to ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 44,241,981 9.37% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: -------------------------------------------------------------------------------------------- The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Friends Provident International Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Life Holdings UK Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Friends Life FPG Limited (wholly owned subsidiary of
Aviva Life Holdings UK Limited) * Friends Life FPL Limited (wholly owned subsidiary of Friends Life FPG Limited) * Friends Life Limited (wholly owned subsidiary of Friends Life FPL Limited) * Friends Life and Pensions Limited (wholly owned subsidiary of Friends Life Limited) * Friends Provident International Limited (wholly owned subsidiary of Friends Life and Pensions Limited) Proxy Voting: -------------------------------------------------------------------------------------------- 10. Name of the proxy holder: See Section 4 -------------------------------------------------- ---------------------------------------- 11. Number of voting rights proxy holder will cease to hold: -------------------------------------------------- ---------------------------------------- 12. Date on which proxy holder will cease to hold voting rights: -------------------------------------------------- ---------------------------------------- 13. Additional information: Figures are based on a total number of voting rights of 471,983,986, as per the Company's Exercise of Share Options announcement of 23(rd) November 2016. -------------------------------------------------- ---------------------------------------- 14. Contact name: Neil Whittaker, Aviva plc -------------------------------------------------- ---------------------------------------- 15. Contact telephone number: 01603 684420 -------------------------------------------------- ----------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEASFEDSLKFFF
(END) Dow Jones Newswires
November 30, 2016 11:00 ET (16:00 GMT)
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions